Abstract: Applications of the FDA Guidance on Common Issues in Drug Development on Rare Diseases

 

Abstract: Applications of the FDA Guidance on Common Issues in Drug Development on Rare Diseases

In August 2015, the US Food and Drug Administration (FDA) released a draft document to address some challenges in developing drugs for rare diseases. The following practical suggestions can be drawn from the FDA guidance.